Metraipolis › archive › dc_06f85d66cc2f
Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study — Europe PMC PMID:38233558
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38233558
- DOI
- 10.1038/s41598-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:01:07.205Z
- SHA-256 of the archived text
cfbd85391ed2ced42c2518fa08040c8eb16e497ba5cce5bad53df77084260161- Stable URL of this page
https://metraipolis.com/documento/dc_06f85d66cc2f
How to cite
Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study — Europe PMC PMID:38233558 — Europe PMC (en), https://europepmc.org/article/MED/38233558 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_06f85d66cc2f (Metraipolis archive dc_06f85d66cc2f, sha256 cfbd85391ed2ced42c2518fa08040c8eb16e497ba5cce5bad53df77084260161)
BibTeX
@misc{dc06f85d66cc2f,
title = {Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study — Europe PMC PMID:38233558},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38233558},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_06f85d66cc2f; sha256 cfbd85391ed2ced42c2518fa08040c8eb16e497ba5cce5bad53df77084260161},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38233558. Agents can read the archived copy with the MCP tool read_document.